Cue Biopharma, Inc.
CUE
$29.47
$0.210.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.70% | -37.02% | -6.88% | -65.76% | -52.07% |
| Total Receivables | 687.83% | -27.47% | -71.20% | -- | -44.35% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 62.61% | 84.92% | 16.11% | -15.94% | -15.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 47.12% | -30.70% | -9.01% | -64.34% | -51.14% |
|
|
|||||
| Total Current Assets | 47.12% | -30.70% | -9.01% | -64.34% | -51.14% |
| Net Property, Plant & Equipment | -10.87% | 6.62% | 1.73% | -35.01% | -31.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -58.68% | -68.95% | 45.36% | -25.18% | -25.22% |
| Total Assets | 31.13% | -29.38% | -3.83% | -58.75% | -47.68% |
|
|
|||||
| Total Accounts Payable | 39.85% | -63.73% | -7.14% | -3.44% | -19.37% |
| Total Accrued Expenses | -44.60% | -41.51% | -66.73% | -18.78% | -29.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -75.73% | -49.13% | -35.42% | -3.12% | 7.39% |
| Total Finance Division Other Current Liabilities | 6,987.06% | 2,917.76% | 881.45% | -70.11% | -95.98% |
| Total Other Current Liabilities | 6,987.06% | 2,917.76% | 881.45% | -70.11% | -95.98% |
| Total Current Liabilities | -1.42% | -7.54% | 16.98% | -14.33% | -19.86% |
|
|
|||||
| Total Current Liabilities | -1.42% | -7.54% | 16.98% | -14.33% | -19.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 127.92% | 102.41% | 58.21% | -93.18% | -68.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.41% | -5.38% | 8.89% | -34.45% | -39.90% |
|
|
|||||
| Common Stock & APIC | 9.89% | 7.15% | 10.26% | 4.98% | 6.23% |
| Retained Earnings | -7.78% | -11.34% | -12.02% | -12.94% | -13.50% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 51.05% | -47.78% | -16.02% | -78.09% | -52.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.05% | -47.78% | -16.02% | -78.09% | -52.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.05% | -47.78% | -16.02% | -78.09% | -52.81% |
|
|
|||||